Larvol Delta - 64CuSARbisPSMA-and-67CuSARbisPSMA-for-Identication-and-Treatment-of-PSMAexpressing-Metastatic-Castrate-Resistant-Prostate-Cancer-SECuRE

64/67Cu SAR-bisPSMA theranostic - Clarity Pharma

http://clinicaltrials.gov/ct2/show/NCT04868604

Aug 13, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next